Iodine-124-AVP 0458

Drug Profile

Iodine-124-AVP 0458

Alternative Names: 124I-PEG-AVP04; AVP-04 - Avipep; AVP-4; I124-AVP 04

Latest Information Update: 28 Dec 2017

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Avipep
  • Class Antibody diagnostics; Imaging agents; Polyethylene glycols; Radiopharmaceutical diagnostics; Radiopharmaceuticals
  • Mechanism of Action Positron-emission tomography enhancers
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • No development reported Ovarian cancer; Prostate cancer

Most Recent Events

  • 28 Dec 2017 No recent reports of development identified for phase-I development in Ovarian-cancer(Diagnosis) in Australia (IV, Infusion)
  • 28 Dec 2017 No recent reports of development identified for phase-I development in Prostate-cancer(Diagnosis) in Australia (IV, Infusion)
  • 29 Aug 2012 Phase-I clinical trials in Ovarian cancer (Diagnosis) in Australia (IV)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top